Glycobiology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Glycobiology Market is Segmented by Product (Enzymes, Instruments, and Kits and Reagents), Application (Diagnostics, Drug Discovery and Development, Oncology, Immunology, and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers market size and forecast values in USD million for the above segments.

Glycobiology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Glycobiology Industry Overview

The glycobiology market is moderately competitive, with the presence of a considerable number of companies that significantly contribute to the market growth. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies adopted by these companies for sustainable growth. Some key companies in the market include Agilent Technologies, Waters Corporation, Shimadzu Corporation, Merck KGaA, and New England Biolabs, among others.

Glycobiology Market Leaders

  1. Agilent Technologies

  2. Waters Corporation

  3. Shimadzu Corporation

  4. Merck KGaA

  5. New England Biolabs

  6. *Disclaimer: Major Players sorted in no particular order
Glycobiology Market Concentration